Qiangqiang Ge

409 citations
18 papers · 229 indexed · h-index 9
Topics
MicroRNA in disease regulation (5 papers)Cancer-related molecular mechanisms research (5 papers)RNA modifications and cancer (3 papers)

In The Last Decade

Qiangqiang Ge

18 papers receiving 229 citations

Peers

Qiangqiang Ge
Comparison fields: 5 of 55
  • Molecular Biology 184
  • Cancer Research 105
  • Pulmonary and Respiratory Medicine 31
  • Oncology 30
  • Surgery 28
Replace Simranjit X. Singh with:
Simranjit X. Singh United States
Rimpi Khurana United States
Hao-Rong Wu China
Yi Fang Guan Australia
Ahlima Roumane United Kingdom
Guihong Zhang China
Valerie Affleck United Kingdom
Peter J. Mullen Canada
Lanqin Cao China
Henry Paik United States
Qiangqiang Ge relative to Simranjit X. Singh United States Simranjit X. Singh's profile →
Citations per field
00.5×
Simranjit X. Singh · 1×
Citations per year

Countries citing papers authored by Qiangqiang Ge

Since Specialization
Citations

This map shows the geographic impact of Qiangqiang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangqiang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangqiang Ge more than expected).

Fields of papers citing papers by Qiangqiang Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangqiang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangqiang Ge. The network helps show where Qiangqiang Ge may publish in the future.

Co-authorship network of co-authors of Qiangqiang Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangqiang Ge. A scholar is included among the top collaborators of Qiangqiang Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangqiang Ge. Qiangqiang Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 2
2 25
3 4
4 7
5 6
6 10
7 44
8
S-phase kinase-associated protein 2 impairs the inhibitory effects of miR-1236-3p on bladder tumors.
8
9 50
10 2
11 1
12 10
13 8
14 29
15 1
16 11
17 8
18 3

About Qiangqiang Ge

Qiangqiang Ge is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 18 papers that have together received 229 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (105 citations), Molecular Biology (184 citations) and Oncology (30 citations). Qiangqiang Ge has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xuefeng Liu, Xinghuan Wang, Chenghe Wang, Gang Wang, Chin‐Lee Wu, Yu Xiao, Zhangqun Ye, Mengxin Lü, Jia Hu and Fan Li. Their work appears in journals such as Cancer Research, International Journal of Cancer and Nature Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026